Skip to content
Delayed ~15 min

ELVN ENLIVEN THERAPEUTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Wed 11 Nov 2026 · estimated

What 17 analyst firms say about ENLIVEN THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

49.43 USD+4.64 (+10.36%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 6 months

Analyst view · last 6M

+47.5%to the avg target 72.93 USD+23.50 USD
Buy 17 · Hold 0 · Sell 1

18 rated views · 19 analyst/firm records · 17 firms

Latest report19 Oct 2026avg report date 11 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MStrong · #13 in the index91
  • Russell 2000 · Safest consensus · 6MGood · #24 in the index83

Recent analyst activity · last 90 days

Our tracked history has 11 reports on ELVN from 11 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 1 left it unchanged and 4 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: H.C. Wainwright raised its target from $64.00 (set 9 Jul 2026) to $73.00 on 19 Oct 2026.

Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdJack K AllenBuy17 Aug 202675.00 USD
BarclaysEtzer DaroutBuy18 Aug 202678.00 USD
Clear Street LLCKaveri PohlmanBuy6 Aug 202668.00 USD
Goldman SachsSalveen RichterBuy6 Aug 202680.00 USD
GuggenheimMichael SchmidtBuy8 Oct 202678.00 USD
GuggenheimMichael SchmitzBuy8 Oct 2026—
H.C. WainwrightRobert BurnsBuy19 Oct 202673.00 USD
JefferiesMaury RaycroftBuy15 Jun 202669.00 USD
JonestradingBoris PeakerBuy29 Jun 202670.00 USD
JonestradingSoumit RoyBuy29 Jun 202670.00 USD
JPMorganPriyanka GroverBuy1 Oct 202675.00 USD
Lifesci CapitalSam SlutskyBuy11 May 202660.00 USD
MizuhoSalim SyedBuy18 Aug 202673.00 USD
Morgan StanleySean LaamanBuy2 Oct 202670.00 USD
StifelDara AzarBuy6 Aug 202682.00 USD
TD CowenPhilip M NadeauBuy8 Oct 2026—
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairAndy HsiehBuy18 Aug 2026—
Data feed RESEARCHResearch TeamSell13 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:50 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.